A Feature on M&A, licensing, and partnership tapping into AI’s potential to improve drug development.

Switzerland-based Novocure saw its shares leap 38% to $27.64 as it revealed positive results from the pivotal, Phase III ...

USA-based rare disease drug developer PTC Therapeutics has signed an exclusive global license and collaboration agreement ...

Donald Trump’s potential re-election may boost biopharma mergers and acquisitions by easing regulatory scrutiny following ...

GLP-1 receptor (GLP-1R) products have gained immense popularity in recent years, and four are currently approved in major ...

Swedish pharma Orexo and Germany-based digital therapeutics company GAIA have decided to end their partnership agreement for ...

Recognizing the full value that vaccines deliver to society and ensuring equitable access to affordable vaccines will be ...

Everest Medicines’ ulcerative colitis treatment Velsipity undergoes Hong Kong regulatory review following successful Phase ...

Alligator Bioscience restructures to prioritize its leading pancreatic cancer treatment, reducing workforce by 70% and ...

Australia’s Department of Health and Aged Care has developed a new API (application programming interface) for the efficient ...

Berlin, Germany-based radioisotopes specialist Eckert & Ziegler Radiopharma today announced the successful start of ...

Biocon Biologics the biosimilars company and subsidiary of Indian drugmaker Biocon, has announced that the US Food and Drug ...